Bowel disease breakthrough as researchers make ‘holy grail’ discovery

Scientists pinpoint driver of IBD and other disorders with work under way to adapt existing drugs to treat patients

Researchers have discovered a major driver of inflammatory bowel disease (IBD) and several other immune disorders that affect the spine, liver and arteries, raising hopes for millions of people worldwide.

The breakthrough is particularly exciting because the newly found biological pathway can be targeted by drugs that are already used, with work under way to adapt them to patients with IBD and other conditions.